Cargando…
Conservative Management of Patent Ductus Arteriosus in Preterm Infants—A Systematic Review and Meta-Analyses Assessing Differences in Outcome Measures Between Randomized Controlled Trials and Cohort Studies
Objective: This study aims to evaluate outcome after conservative management (no pharmacological/surgical intervention other than fluid restriction, diuretics, or ventilator adjustments) compared with active (pharmacological and/or surgical) treatment for patent ductus arteriosus (PDA) in preterm in...
Autores principales: | Hundscheid, Tim, Jansen, Esther J. S., Onland, Wes, Kooi, Elisabeth M. W., Andriessen, Peter, de Boode, Willem P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946967/ https://www.ncbi.nlm.nih.gov/pubmed/33718300 http://dx.doi.org/10.3389/fped.2021.626261 |
Ejemplares similares
-
Factors Associated With Benefit of Treatment of Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis
por: Jansen, Esther J. S., et al.
Publicado: (2021) -
Multi-centre, randomised non-inferiority trial of early treatment versus expectant management of patent ductus arteriosus in preterm infants (the BeNeDuctus trial): statistical analysis plan
por: Hundscheid, Tim, et al.
Publicado: (2021) -
Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants
por: Arlettaz, Romaine
Publicado: (2017) -
Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants
por: Coviello, Caterina, et al.
Publicado: (2020) -
Editorial: Management of Patent Ductus Arteriosus in Preterm Infants
por: Atasay, Begüm, et al.
Publicado: (2021)